Effects of long-term grapefruit juice ingestion on nifedipine pharmacokinetics: Induction of rat hepatic P-450 by grapefruit juice

Drug Metabolism and Disposition

Volumn 28, Issue 4, 2000, Pages 482-486

  Mohri, Kiminori ^a   Uesawa, Yoshihiro ^a   Sagawa, Ken Ichi ^b  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NIFEDIPINE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG CLEARANCE; DRUG METABOLISM; ENZYME INDUCTION; FRUIT JUICE; GRAPE; LIVER MICROSOME; MALE; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT;

ANIMALS; AREA UNDER CURVE; BEVERAGES; CALCIUM CHANNEL BLOCKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CITRUS; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; HALF-LIFE; MALE; MICROSOMES, LIVER; NIFEDIPINE; RATS; RATS, WISTAR;

ANIMALIA; CITRUS X PARADISI; VITIS SP.;

EID: 0034029572     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Bailey DG, Malcolm J, Arnold O and Spence JD (1998) Grapefruit juice-drug interactions. Br J Clin Pharmacol 46:101-110.
2. Bailey DG, Spence JD, Munoz C and Arnold JM (1991) Interaction of citrus juices with felodipine and nifedipine. Lancet 337:268-269.
3. Bickers DR and Pathak MA (1984) Psoralen pharmacology: Studies on metabolism and enzyme induction. Natl Cancer Inst Monogr 66:77-84.
4. Blychert E, Edgar B, Elmfeldt D and Hedner T (1991) A population study of the pharmacokinetics of felodipine. Br J Clin Pharmacol 31:15-24.
5. Bonkovsky HL, Hauri HP, Marti U, Gasser R and Meyer UA (1985) Cytochrome P450 of small intestinal epithelial cells. Immunochemical characterization of the increase in cytochrome P450 caused by phenobarbital. Gastroenterology 88:458-467.
6. Brunner LJ, Munar MY, Vallian J, Wolfson M, Stennett DJ, Meyer MM and Bennett WM (1998) Interaction between cyclosporine and grapefruit juice requires long-term ingestion in stable renal transplant recipients. Pharmacotherapy 18:23-29.
7. Diawara MM, Chavez KJ, Hoyer PB, Williams DE, Dorsch J, Kulkosky P and Franklin MR (1994) A novel group of ovarian toxicants: The psoralens. J Biochem Mol Toxicol 13:195-203.
8. Edgar B, Regardh CG, Lundborg P, Romare S, Nyberg G and Ronn O (1987) Pharmacokinetic and pharmacodynamic studies of felodipine in healthy subjects after various single, oral and intravenous doses. Biopharm Drug Dispos 8:235-248.
9. Edwards DJ, Fitzsimmons ME, Schuetz EG, Yasuda K, Ducharme MP, Warbasse I.H. Woster PM, Schuetz JD and Watkins P (1999) 6′,7′-Dihydroxybergamottin in grapefruit juice and Seville orange juice: Effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein. Clin Pharmacol Ther 65:237-244.
10. Fuhr U (1998) Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance. Drug Saf 18:251-272.
11. Fukuda K, Ohta T, Oshima Y, Ohashi N, Yoshikawa M and Yamazoc Y (1997) Specific CYP3A4 inhibitors in grapefruit juice: Furocoumarin dimers as components of drug interaction. Pharmacogenetics 7:391-396.
12. Grundy JS, Eliot LA, Kulmatycki KM and Foster RT (1998) Grapefruit juice and orange juice effects on the bioavailability of nifedipine in the rat. Biopharm Drug Dispos 19:175-183.
13. Gupta SK and Benet LZ (1989) Absorption kinetics of cyclosporine in healthy volunteers. Biopharm Drug Dispos 10:591-596.
14. Gwang JH (1996) Induction of rat hepatic cytochrome P4501A and P4502B by the methoxsalen. Cancer Lett 109:115-120.
15. He K, Iyer KR, Hayes RN, Sinz MW, Woolf TF and Hollenberg PF (1998) Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice. Chem Res Toxicol 11:252-259.
16. Kahan BD, Welsh M, Schoenberg L, Rutzky LP, Katz SM, Urbauer DL and Van Buren CT (1996) Variable oral absorption of cyclosporine. A biopharmaceutical risk factor for chronic renal allograft rejection. Transplantation 62:599-606.
17. Letteron P, Descatoire V, Larrey D, Tinel M, Geneve J and Pessayre D (1986) Inactivation and induction of cytochrome P-450 by various psoralen derivatives in rats. J Pharmacol Exp Ther 238:685-692.
18. Litterst CL, Mimnaugh EG, Reagan RL and Gram TE (1975) Drug metabolism by microsomes from extrahepatic organs of rat and rabbit prepared by calcium aggregation. Life Sci 17:813-818.
19. Lown KS, Bailey DG, Fontana RJ, Janardan SK, Adair CH, Fortlage LA, Brown MB, Guo W and Watkins PB (1997) Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression. J Clin Invest 99:2545-2553.
20. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
21. Lundahl JU, Regardh CG, Edgar B and Johnsson G (1998) The interaction effect of grapefruit juice is maximal after the first glass. Eur J Clin Pharmacol 54:75-81.
22. Mandula BB, Pathak MA, Nakayama Y and Davidson SJ (1978) Induction of mixed-function oxidases in mouse liver by psoralens. Br J Dermatol 99:687-692
23. Raemseh KD and Sommer J (1983) Pharmacokinetics and metabolism of nifedipine. Hypertension 5:II18-24.
24. Rashid TJ, Martin U, Clarke H, Waller DG, Renwick AG and George CF (1995) Factors affecting the absolute bioavailability of nifedipine. Br J Clin Pharmacol 40:51-58
25. Schmiedlin-Ren P, Edwards DJ, Fitzsimmons ME, He K, Lown KS, Woster PM, Rahman A, Thummel KE, Fisher JM, Hollenberg PF and Watkins PB (1997) Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins. Drug Metab Dispos 25:1228-1233.
26. Soldner A, Christians U, Susanto M, Wacher VJ, Silverman JA and Benet LZ (1999) Grapefruit juice activates P-glycoprotein-mediated drug transport. Pharm Res 16:478-485.
27. Takanaga H, Ohnishi A, Matsuo H and Sawada Y (1998) Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in caco-2 cells. Biol Pharm Bull 21:1062-1066.
28. Yamaoka K and Nakagawa T (1983) A nonlinear least squares program based on differential equations, MULTI (RUNGE), for microcomputers. J Pharmacobiodyn 6:595-606.
29. Yamaoka K, Nakagawa T and Uno T (1978) Statistical moments in pharmacokinetics. J Pharmacokinet Biopharm 6:547-558.
30. Yamreudeewong W, Henann NE, Fazio A, Lower DL and Cassidy TG (1995) Drug-food interactions in clinical practice. J Fam Pract 40:376-384.